BioCentury
ARTICLE | Company News

Boehringer Ingelheim invests €230M in new biologics center

June 29, 2018 9:18 PM UTC

Boehringer Ingelheim GmbH (Ingelheim, Germany) will invest €230 million ($268 million) in a new biologicals development center at its R&D site in Biberach, Germany...

BCIQ Company Profiles

Boehringer Ingelheim GmbH